financetom
Business
financetom
/
Business
/
dynaCERT Nearer 52 Week Lows As Closes $5 Million Non-Brokered Equity Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
dynaCERT Nearer 52 Week Lows As Closes $5 Million Non-Brokered Equity Offering
Jul 2, 2025 1:15 PM

03:30 PM EDT, 07/02/2025 (MT Newswires) -- dynaCERT (DYA.TO) was slightly lower and nearer 52 week lows Wednesday after closing its previously announced non-brokered private placement offering of units, issuing 33.33 million units at a price of $0.15 each for aggregate gross proceeds of up to $5 million.

According to a company statement, each unit is comprised of one common share of the company and one common share purchase warrant. Each warrant is exercisable into one common share for $0.20 per warrant for a period of 36 months

dynaCERT intends to use the proceeds to finance sales of the company's HydraGEN Technology products to participants in the mining, oil & gas, transportation and generator sectors on a global basis and for working capital and for general corporate purposes.

The company is trading down $0.005 at $0.135 a share, near a 52 week low of $0.13.

Price: 0.14, Change: -0.01, Percent Change: -3.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Protara Therapeutics Q3 net loss widens
Protara Therapeutics Q3 net loss widens
Nov 10, 2025
Overview * Protara reports Q3 net loss of $13.3 mln, increased from $11.2 mln in 2024 * Company anticipates key clinical milestones in late 2025 and early 2026 Outlook * Protara expects interim results from NMIBC trial in 1Q 2026 * Company plans to initiate dosing in THRIVE-3 trial by year-end 2025 * Protara expects cash reserves of $134 mln...
Motorcar Parts of America's Q2 sales beat on inventory realignment
Motorcar Parts of America's Q2 sales beat on inventory realignment
Nov 10, 2025
Overview * Motorcar Parts fiscal Q2 net sales rise 6.4%, beating analyst expectations * Company reports record gross profit for fiscal Q2 at $42.7 mln * Company repurchased 90,114 shares for $1.4 mln, indicating strong cash flow Outlook * Company did not provide specific financial guidance for future quarters or fiscal year Result Drivers * INVENTORY REALIGNMENT - Net sales...
Global Ship Lease Q3 gains on higher charter demand; dividend raised
Global Ship Lease Q3 gains on higher charter demand; dividend raised
Nov 10, 2025
Overview * Global Ship Lease Q3 2025 operating revenue grows 10.7% yr/yr * Net income for Q3 2025 rises 17.5% yr/yr * Company increases annualized dividend to $2.50 per share Outlook * Company has forward contract cover locked for 100% of 2025 and 96% of 2026 * Company sees geopolitical complexities impacting containership supply chain efficiency Result Drivers * CHARTER...
Belite Bio Q3 net loss widens on higher R&D expenses 
Belite Bio Q3 net loss widens on higher R&D expenses 
Nov 10, 2025
Overview * Belite Bio ( BLTE ) reports Q3 net loss of $21.7 mln, increased from $8.7 mln last year * Company completed $15 mln direct offering and $125 mln private placement * China's NMPA and UK's MHRA accept Tinlarebant applications based on DRAGON trial Outlook * Company expects final DRAGON trial data in Q4 2025 * Company anticipates interim...
Copyright 2023-2026 - www.financetom.com All Rights Reserved